Truncated isoforms inhibit [ 3 H]prazosin binding and cellular trafficking of native human α 1A -adrenoceptors
Francis COGE ! 1 , Sophie-Pe! ne! lope GUENIN, Anne RENOUARD-TRY, Herve! RIQUE, Christine OUVRY, Nelly FABRY, Philippe BEAUVERGER, Jean-Paul NICOLAS, Jean-Pierre GALIZZI, Jean A. BOUTIN and Emmanuel CANET We have identified from human liver eight α "A -adrenoceptor (α "A -AR) splice variants that were also expressed in human heart, prostate and hippocampus. Three of these α "A -AR isoforms (α "A-" -AR, α "A-#a -AR and α "A-$a -AR) gave rise to receptors with seven transmembrane domains (7TMα "A -AR). The other five (α "A-#b -AR, α "A-#c -AR, α "A-$c -AR, α "A-& -AR and α "A-' -AR) led to truncated receptors lacking transmembrane domain VII (6TMα "A -AR). The 7TMα "A -AR isoforms transiently expressed in COS-7 cells bound [$H]prazosin with high affinity (K d 0.2 nM) and mediated a noradrenaline (norepinephrine)-induced increase in cytoplasmic free Ca# + concentration, whereas the 6TMα "A -AR isoforms were incapable of ligand binding and signal transduction. Immunocytochemical studies with N-terminal epitopetagged α "A -AR isoforms showed that the 7TMα "A -AR isoforms were present both at the cell surface and in intracellular com-
INTRODUCTION
α " -Adrenoceptors (α " -AR isoforms) are members of the superfamily of seven-transmembrane-domain (7TM) G-proteincoupled receptors that bind the endogenous catecholamines adrenaline (epinephrine) and noradrenaline (norepinephrine) [1] . Three α " -AR subtypes (α "A , α "B and α "D ; for new IUPHAR α " -AR nomenclature see [2] ) have been cloned, expressed in several cells and characterized pharmacologically [3] [4] [5] . The α " -AR isoforms mediate, via G q α activation of phospholipase Cβ, various sympathetic nervous system responses such as smoothmuscle contraction, myocardial inotropy and hepatic glucose metabolism [1] .
Clinically, the α "A -AR subtype was postulated to mediate smooth-muscle contraction in human prostate, suggesting a role for this receptor in the bladder outlet obstruction observed in patients with benign prostate hypertrophy [6, 7] . α "A -AR also seems implicated in the development of myocardial hypertrophy [8] . An increase in α "A mRNA level and protein expression has been observed in these two pathologies [9, 10] . Despite the importance of α "A -AR in physiopathological states, few studies have examined the regulatory mechanisms of the expression and biological function of α "A -AR. Unlike the α "B -AR and α "D -AR subtypes, which are expressed as a unique receptor form, four isoforms of α "A -AR (α "A-" , α "A-# , α "A-$ and α "A-% ) have been isolated from a human prostate cDNA library [11, 12] . Although α "A-# , α "A-$ and α "A-% -AR differ from the ' original ' α "A-" -AR [3] in length and sequence in the C-terminal region, these four α "A -AR isoforms were indistinguishable with regard to their pharmacological profiles and their abilities to Abbreviations used : AR, adrenergic receptor (adrenoceptor) ; [Ca 2 + ] i , cytoplasmic free Ca 2 + concentration ; RT-PCR, reverse-transcriptase-mediated PCR ; TM, transmembrane domain. 1 To whom correspondence should be addressed (e-mail coge!servier.fr).
partments, whereas the 6TMα "A -AR isoforms were exclusively localized within the cell. Interestingly, in co-transfected cells, each truncated α "A -AR isoform inhibited [$H]prazosin binding and cell-surface trafficking of the co-expressed ' original ' 7TMα "A-" -AR. However, there was no modification of either the [$H]prazosin-binding affinity or the pharmacological properties of α "A-" -AR. Immunoblotting experiments revealed that coexpression of the α "A-" -AR with 6TMα "A -AR isoforms did not impair α "A-" -AR expression. Therefore the expression in human tissues of many truncated isoforms constitutes a new regulation pathway of biological properties of α "A -AR.
Key words : coexpression, heterodimerization, receptor dimer, regulation of G protein-coupled receptors.
mediate noradrenaline-induced cytoplasmic Ca# + release [3, 11, 12] . Non-functional truncated isoforms have been also observed in human prostate and hippocampus [12, 13] but were not extensively studied. The physiological significance of α "A -AR splice variants is currently unknown.
The expression of non-functional truncated isoforms (V #nf and D $nf ), which was correlated with the loss of the wild-type receptor, was observed for human vasopressin V # receptor in kidney from patients with X-linked nephrogenic diabetes insipidus [14] and for human dopamine D $ receptor in cerebral cortex from patients with chronic schizophrenia respectively [15] [16] [17] . In the latter, the loss of D $ mRNA results from an increased frequency of D $nf alternative splicing of D $ pre-mRNA [17] . In addition to this accumulation of truncated D $nf mRNA, oligomerization occurs between this truncated form and the wild-type D $ receptor [18] . For V # receptor, Zhu and Wess [19] demonstrated by coexpression in COS-7 cells that the formation of heterodimers between truncated mutants and wild-type V # receptors led to an important decrease in agonist binding, signal transduction and cell-surface trafficking of the full-length V # receptor. These results revealed two methods of regulation of the G-protein-coupled receptor : (1) via the modification of alternative splicing that changes the receptor mRNA level and (2) via the interactions between truncated receptor isoforms that inactivate the biological function of the receptor. It is thus crucial to determine whether α "A -AR isoforms could form heterodimers and whether such interactions might be modified in pathological situations (benign prostate hypertrophy and myocardial hypertrophy).
In the present study, eight α "A -AR splice variants have been isolated from human liver. Their characterization demonstrates the existence of four new α "A -AR isoforms. Co-expression in COS-7 cells of α "A -AR isoforms revealed that only truncated isoforms showed modified [$H]prazosin binding and cell-surface trafficking from that of the ' original ' α "A-" -AR.
EXPERIMENTAL cDNA library screening and reverse-transcriptase-mediated PCR (RT-PCR)
Recombinant clones (2i10') of human liver λgt11 library (Clontech) were screened with a 1.4 kbp PCR fragment corresponding to the complete coding sequence of human α "A -AR [3] by a standard procedure [20] . cDNA species for α "A-#b -AR, α "A-#c -AR, α "A-$b -AR and α "A-$c -AR were isolated by RT-PCR from human liver mRNA (Clontech) by using a 5h sense primer (nt 432-452 of human α "A-" -AR [3] ) and two specific 3h-anti-sense primers, respectively nt 2044-2067 of human α "A-# -AR [11] and nt 1942-1963 of human α "A-$ -AR [11] . Liver total RNA (2 µg) was reverse-transcribed with oligo(dT) "# -") and N6 oligonucleotides in accordance with the first-strand cDNA synthesis protocol from Pharmacia Biotech. PCR reactions were performed in 100 µl containing 10 mM Tris\HCl, pH 8.3, 1.5 mM MgCl # , 0.2 mM dNTP, 2 µl of the single-stranded cDNA preparation, 0.3 µM of each primer and 2 units of Amplitaq Gold polymerase (Perkin-Elmer Cetus) with a 35-cycle programme of 94 mC for 1 min, 55 mC for 2 min and 72 mC for 2 min, a hot start at 94 mC for 9 min and a final extension at 72 mC for 8 min. Cloned cDNA and PCR products were subcloned into pUC18 (Biolabs) and pGEMT-easy (Promega) respectively. Nucleotide sequence analysis on both DNA strands was performed on a ABI377 DNA sequencer (Applied Biosystems).
Tissue expression
The mRNA species of human tissues were purchased from Clontech. First-strand cDNA synthesis was performed from 250 ng of mRNA and amplified as described above. PCR primers were designed for all α "A -AR isoforms : the forward primer (5h-AAGAAAGCGGCCAAAACGCTGG-3h ; position 1238-1259 of α "A-" -AR [3] ) was common to all isoforms and reverse primers were specific to α "A -AR isoforms [3h-GTCACTCTTGCCCCTC-CTTCAGATC-5h (position 1813-1837 [3] 
Plasmid construction and flag epitope tagging
PCR fragments of complete coding regions of all isolated α "A -AR isoforms were inserted between EcoRI and XbaI sites of the pSRα expression vector [21] . The M5 flag epitope (sequence DYKDDDDK) was introduced into these α "A receptor expression constructs at the N-terminus between the first methionine residue and the second residue of α "A -AR isoforms.
Immunofluorescence microscopy 4 , and immediate filtering through Whatman GF\B glass fibre filters presoaked in 0.1 % polyethylenimine with a Brandel cell harvester. Filters were washed twice and radioactivity was measured. Non-specific binding was determined in the presence of 10 µM phentolamine and was usually not more than 10 % of total binding. To determine the subcellular distribution of [$H]prazosin-binding sites, radioligand binding was performed on whole cells in a manner similar to that described by Eason and Liggett [22] . Transfected cells were resuspended in ice-cold Ham's F12 medium, then incubated with increasing concentrations (0.02-3 nM) of [$H]prazosin in the absence or the presence of the lipophilic competitor phentolamine (10 µM) or the hydrophilic competitor adrenaline (100 µM) for 4 h at 4 mC. In intact cells, adrenaline, owing to its hydrophilic properties, is unable to penetrate the plasma membrane, especially at 4 mC. Surfaceaccessible binding was thus defined as the binding displaced by 100 µM adrenaline. Total specific binding was defined as the binding displaced by 10 µM phentolamine. The difference between surface-accessible and total binding represents the intracellular specific binding. Saturation and displacement curves were analysed by non-linear regression analysis with the In Plot program (GRAPHPAD Software). The statistical significance of differences between mean data was evaluated by the use of the Dunnett test. The difference was taken to be significant when P 0.05. The drugs were purchased from Sigma and Research Biochemicals.
Ca 2 + mobilization assay
Transfected COS-7 cells were detached by incubation in PBS without Ca# + and Mg# + for 10 min at 37 mC, centrifuged at 1000 g for 5 min and incubated at 10' cells\ml in Hanks medium containing 0.1 % BSA and 5 µM fura-2 acetoxymethyl ester for 30 min at 37 mC. Noradrenaline (10 µM)-induced cytoplasmic Regulation of α 1A -adrenoceptor by truncated isoforms 
RESULTS

Cloning of human α 1A -AR cDNA species from human liver
Screening of human liver cDNA library with a probe corresponding to the complete coding sequence of human α "A−" -AR [3] and RT-PCR amplification of liver mRNA with primers specific for α "A−# -AR and α "A−$ -AR enabled us to identify nine splice variants of
-AR. Our nomenclature follows that used for the α "A -AR
Figure 1 Deduced C-terminal amino acid sequences of α 1A -AR isoforms isolated from human liver
Deduced sequences after their 294th residue are presented in single-letter code. The residues in TM7 are indicated in bold. The corresponding amino acid sequence differences from the published α 1A − 2 -AR sequence [11] are underlined. A deletion of a guanosine residue at position 1827 in the α 1A − 2a -AR sequence [11] resulted in a frame shift after the 464th residue and introduced a stop codon after the 475th residue.
Figure 2 Distribution of mRNA encoding α 1A -AR isoforms in human tissues
mRNA (250 ng) of human liver, heart, prostate and hippocampus was amplified by RT-PCR between a common 5h sense primer and a 3h anti-sense primer specific to each isoform, as described in the Experimental section. After 30 cycles of PCR for α 1A − 1 -AR and 40 cycles of PCR for other α 1A -AR isoforms, PCR products were analysed in agarose gel stained by ethidium bromide. The length of PCR fragments was estimated by molecular mass markers (ΦX174/Hae III) and is indicated in base pairs at the right.
isoforms cloned previously [11, 12] . The α "A−" -AR, α "A−#a -AR and α "A−$a -AR cDNA species corresponded to the three isoforms previously identified from human prostate cDNA library by Hirasawa et al. [3, 11] . We did not identify the splice variant α "A−% -AR cloned by Chang et al. [12] . The α "A−#a -AR, α "A−#b -AR and α "A−#c -AR cDNA species presented identical sequences at the 5h and 3h ends but diverged between nt 1320 and 1705 (α "A−#a -AR [11] ). An identical alternative splicing was observed for the α "A−$a -AR, α "A−$b -AR and α "A−$c -AR cDNA species. The α "A−#b -AR and α "A−$b -AR cDNA species encoded the same α "A receptor (Figure 1 ). The sizes of the eight isolated α "A -AR isoforms ranged from 297 to 475 residues. The primary sequences of these α "A -AR isoforms were identical before the 294th residue and then diverged. Deduced C-terminal amino acid sequences of the eight α "A -AR isoforms are shown in Figure 1 . Hydropathy analysis [24] of protein sequences revealed the presence of seven hydrophobic clusters of 20-25 residues for the α "A−" -AR, α "A−#a -AR and α "A−$a -AR isoforms and showed the loss of TM7 for the α "A−#b
Tissue expression
The expression of mRNA encoding the isolated α "A -AR isoforms was investigated in the human heart, liver, prostate and hippocampus by RT-PCR with a common 5h sense primer and isoform-specific 3h anti-sense primers. The eight mRNA species encoding the α "A -AR isoforms were amplified from the four tissues (Figure 2 ). With the same 5h and 3h primers, we observed that the mRNA encoding α "A−#a -AR was more abundantly expressed than those encoding the truncated α "A−#b -AR and α "A−#c -AR ( Figure 2) ; the α "A−$a -AR mRNA seemed to be more abundant than those encoding the α "A−$b -AR and α "A−$c -AR isoforms (Figure 2 ). Although our PCR experiments were not quantitative, the mRNA encoding α "A−' -AR seemed to be expressed more in liver than in the other tissues analysed (Figure 2 ).
Radioligand binding and agonist-induced [Ca 2 + ] i increase
To examine the pharmacological and biochemical properties of the isolated α "A -AR isoforms, PCR fragments corresponding to the coding region of each α "A -AR isoform were inserted into the pSRα expression vector and used to transfect COS-7 cells transiently. Membranes from COS-7 cells transfected with α "A−" -AR, α "A−#a -AR or α "A−$a -AR were able to bind [$H]prazosin in a saturable manner with high affinity (K d 0.22p0.03 nM). The expression levels of α "A−" -AR, α "A−#a -AR and α "A−$a -AR were respectively 14, 13 and 15 pmol\mg of protein. COS-7 cells transfected either with pSRα alone or 6TM-α "A -AR isoforms
-AR) exhibited no specific binding. Binding of [$H]prazosin to cell membranes expressing α "A−" -AR, α "A−#a -AR or α "A−$a -AR was inhibited with a similar rank order of potency by adrenergic agonists or antagonists (Table 1 ). In COS-7 cells expressing the isoforms α "A−" -AR, α "A−#a -AR or α "A−$a -AR, noradrenaline elicited a rapid and transient increase in [Ca# + ] i ; maximal stimulation was achieved with 10 µM noradrenaline (results not shown). The noradrenaline (10 µM)-induced [Ca# + ] i response was similar in potency (66p6 nM) for the three isoforms (Table 1) and its amplitude was 10-fold higher than that measured in COS-7 cells transfected with the vector alone. In contrast, noradrenaline (10 µM) did not increase [Ca# + ] i in COS-7 cells transfected with 6TM-α "A -AR isoforms.
Subcellular localization
The subcellular localization of α "A -AR isoforms was studied with N-terminal M5 epitope-tagged recombinant α "A -AR isoforms transiently expressed in COS-7 cells. The tagged receptors were detected with anti-M5-specific antibodies and Cy3 TM conjugate anti-mouse IgG antibodies. No fluorescent signal was detected from COS-7 cells transfected with the vector alone (results not shown). In non-fixed and non-permeabilized transfected COS-7 cells, the fluorescent signal was detected at the surface of cells expressing the M5-tagged 7TMα "A−" -AR isoform ( Figure 3A ), whereas no signal was observed in cells expressing the M5-tagged 6TMα "A−$c -AR isoform ( Figure 3C ). Furthermore, when cells expressing either the M5-tagged α "A−" -AR or M5-tagged α "A−$c -AR isoform were fixed and permeabilized, a strong red fluorescence was observed in the perinuclear region ( Figures 3B and  3D) . Finally, we observed that M5-tagged α "A−#a -AR and α "A−$a -AR isoforms were localized at the cell surface and in intracellular compartments, as was α "A−" -AR, whereas the α "A−#b
-AR isoforms were stocked exclusively in the perinuclear compartment, as was α "A−$c -AR (results not shown). The subcellular distribution of [$H]prazosinbinding sites were determined by using radioligand binding in intact transfected COS-7 cells and unlabelled competitors phentolamine (lipophilic antagonist) and adrenaline (hydrophilic agonist) to delineate the total and plasma membrane binding sites respectively. Intracellular binding sites were determined as the difference of the two binding values. The results showed that measurable binding sites were about 10-fold more abundant at the cell surface (2870p432 fmol per 10' cells) than within intracellular compartments (230p40 fmol per 10' cells) ( Table 2) .
Co-expression of α 1A -AR isoforms
To examine whether co-expressed α "A -AR isoforms interfered with the ability of ' original ' α "A−" -AR to bind [$H]prazosin, intact co-transfected COS-7 cells were tested for their capacity to bind the radioligand. These studies showed that the co-transfection of α Table 2 ). The equilibrium dissociation constants were not modified (K d 0.42p0.02 nM)
Figure 5 Immunoblotting of human α 1A -AR isoforms expressed in COS-7 cells
Membrane proteins (10 µg) from COS-7 cells expressing each epitope-tagged α 1A -AR isoform (A) or from COS-7 cells co-expressing M5 epitope-tagged α 1A − 1 -AR isoform and untagged α 1A -AR isoforms (B) were separated by SDS/PAGE and transferred to nitrocellulose filters, as described in the Experimental section. Filters were incubated with anti-M5 antibody. Detection of primary antibody binding was performed with a specific horseradish-peroxidase-linked secondary antibody followed by enhanced-chemiluminescence-directed exposure to Hyperfilm. The blots were calibrated with Rainbow molecular mass markers (Amersham), as indicated at the left. The estimated molecular masses of the α 1A -AR isoforms are indicated at the right. Each blot is representative of three independent experiments. Table 2) .
Our next goal was to determine whether truncated α "A -AR isoforms were able to interfere with the cell-surface localization of the co-expressed M5-tagged α "A−" -AR. For this purpose we determined the percentage of immunostained co-transfected cells that were non-fixed and non-permeabilized. Strikingly, co-expression of M5-tagged α "A−" -AR with the truncated non-tagged
-AR isoforms led to a strong decrease (approx. 56 %) in the number of immunofluorescent cells in comparison with COS-7 cells expressing M5-tagged α "A−" -AR alone (Figure 4) . No decrease in the number of immunofluorescent cells was observed when M5-tagged α "A−" -AR was co-transfected with the α "A−#a -AR or α "A−$a -AR isoforms (Figure 4) . We also observed that 5 % of the cells co-expressing untagged α "A−" -AR and M5-tagged 6TMα
-AR) presented a fluorescent signal at the cell surface (1000 cells analysed for each isoform ; results not shown). Regulation of α 1A -adrenoceptor by truncated isoforms
Western blot analysis
Western blot analysis of SDS-treated membrane fractions of COS-7 cells transfected with tagged α "A -AR with the use of an anti-M5 antibody revealed immunoreactive polypeptides corresponding to lower (35-42 kDa) as well as intermediate (55-70 kDa) and higher (110-140 and 165-210 kDa) molecular mass species ( Figure 5A ). All these detected proteins seemed to be related to M5 epitope-tagged α "A -AR because no polypeptide was detected when cells were transfected with the vector alone ( Figure 5A ). Furthermore, when cells were transfected with various α "A -AR isoforms, including α "A−" -AR (466 residues), α "A−#a -AR (475 residues), α "A−$a -AR (429 residues), α "A−$c -AR (372 residues) and α "A−' -AR (342 residues), the pattern of detected polypeptides followed the change in calculated molecular mass based on amino acid compositions. SDS\PAGE and autoradiography of photolabelled membranes of COS-7 cells expressing α "A−" -AR with ["#&I]iodoarylazidoprazosin revealed a single major polypeptide of 65 kDa (results not shown). Therefore the intermediate peptides (55-70 kDa) might be monomeric glycosylated α "A -AR, with slightly higher molecular masses than those expected by calculation for each α "A -AR. The lower-molecularmass species (30-42 kDa) might result from the degradation of the cytoplasmic tail of intermediate polypeptides. The highmolecular-mass polypeptides (110-140 and 165-210 kDa) were 2-fold or 3-fold the intermediate one (50-70 kDa), suggesting that they might be homodimers or homotrimers of α "A -AR isoforms respectively. Quantification by densitometry of autoradiography obtained with the COS-7 cells expressing M5 epitope-tagged α "A−" -AR along with an untagged 7TMα
-AR) isoform showed that the four protein bands (40, 65, 130 and 195 kDa) had similar intensities to those revealed in COS-7 cells expressing M5-tagged α "A−" -AR alone ( Figure 5B ). Therefore co-transfected 7TMα "A -AR or 6TMα "A -AR isoforms did not modify M5-tagged α "A−" -AR protein expression and did not disrupt the oligomerization of α "A−" -AR.
DISCUSSION
α "A -AR, which is the predominant α " -AR in prostate and heart, seems to be important in benign prostatic hyperplasia and cardiac hypertrophy [6] [7] [8] . However, the regulation of the expression and function of α "A -AR in these pathologies remains unknown. In the present study we have cloned and characterized several splice variants of α "A -AR. With the use of co-expression experiments in COS-7 cells, we have analysed the interactions between these α "A -AR isoforms and the ' original ' α "A−" receptor to determine whether the splice variants could modify the biological properties of α "A−" -AR. Although its structure is not yet completely known, the human gene for α "A -AR differs from other human AR genes by the existence of several introns [11, 12, 25] . Our present study, together with those of Hirasawa et al. [11] and Chang et al. [12] , revealed that at least 12 α "A -AR isoforms existed, deriving from a complex alternative splicing of the gene for α "A -AR. It is interesting to note that all isolated cDNA species diverged after nt 1320 (Figure 1) , which corresponded to the junction of TM6 and the third extracellular loop, a location at which Razik et al. [25] demonstrated the presence of a large intron (more than 9 kb). Four of the twelve cloned α "A -AR isoforms (α "A−" -AR, α "A−#a -AR, α "A−$a -AR and α "A−% -AR) presented a G-protein-coupled receptor structure and differed only in their C-terminal regions (Figure 1 ). The role of the different C-terminal sequences remains to be elucidated. The eight other isoforms lack TM7 and their Cterminal tails are located extracellularly (Figure 1) . In the present study, the functional analysis of the truncated six-TM α "A−#b
-AR showed that these receptors were unable to bind the α " -antagonist [$H]prazosin and did not respond to adrenaline by an increase in
To study the tissue distribution of the mRNA encoding the different isolated isoforms, RT-PCR analysis was performed on human tissues that were known for their high expression of α "A -AR transcripts. All nine mRNA species encoding α "A−" -AR,
-AR were co-expressed in human liver, heart, prostate and hippocampus, thus displaying no tissue specificity (Figure 2 ). The mRNA of the α "A -AR isoforms containing seven TMs (α "A−" -AR, α "A−#a -AR and α "A−$a -AR) seemed to be more abundant than the truncated isoforms lacking TM7. This latter observation is in accord with the results for the human V # vasopressin [26] and mouse neuropeptide Y-Y " receptors [27] ;f the truncated isoforms represented approx. 15 % of total receptors.
The existence of interactions between the α "A -AR isoforms was examined by transient co-expression in COS-7 cells. Co-expression of the ' original ' α "A−" -AR with one of the seven other isolated isoforms demonstrated that the α "A−#a -AR and α "A−$a -AR isoforms, which possess seven TMs, modified neither the expression level nor the pharmacological properties of α "A−" -AR (Table 1) . In contrast, co-expression of truncated isoforms
-AR without modifying its pharmacological properties (Tables 1 and 2 ). Western blot analysis showed that this decrease was not linked to a diminution of the expression of α "A−" -AR in co-transfected cells ( Figure 5B ). This decrease in binding was specific for the truncated isoforms because no decrease was observed when α "A−#a -AR, α "A−$a -AR or interleukin 4 receptor was co-expressed with α "A−" -AR (Table 2) . A 50 % decrease in agonist binding has been described for the V # vasopressin and gonadotropin-releasing hormone receptors when wild-type receptors were co-expressed with truncated isoforms lacking TM6 and TM7 [19, 27] . For both receptors, this decrease in binding sites was related to a decrease in cell-surface trafficking and in signal transduction of the wild-type receptor [19, 28] . Subcellular localization of α "A−" -AR examined by immunocytochemistry revealed a high concentration of α "A−" -AR isoforms in the perinuclear region ( Figure 3B ). This subcellular distribution of α "A−" -AR differed clearly from the distribution of α "B -AR, which was massively expressed at the cell surface [29, 30] . A subcellular localization similar to that of α "A−" -AR has been observed for α #C -AR [31] but the physiological and functional relevance of such a large intracellular receptor pool remains unknown. However, similarly to α #C -AR [22] , binding experiments using intact cells revealed that most measurable [$H]-prazosin-binding sites were located at the cell surface (92p9 % of binding sites). The result was similar to those obtained with HEK-293 cells expressing bovine α "A -AR (87p7 % of "#&I-BE2254-binding sites at the cell surface) by Theroux et al. [32] . Most of the α "A -AR in intracellular storage might therefore have an unfavourable conformation for recognition of the radioligand. Despite the small amount of cell-surface α "A-" -AR isoforms, we could observe by immunocytochemistry that co-expression of M5-tagged α "A-" -AR with truncated untagged α "A -AR isoforms profoundly inhibited (by approx. 56 %) the appearance of α "A−" -AR at the plasma membrane (Figure 4) . These results suggested that the impaired insertion of α "A−" -AR into the plasma membrane might be the molecular mechanism underlying the specific negative effect of the co-expressed truncated α "A -AR isoforms. The unexpected decrease in the number of intracellular [$H]-prazosin-binding sites, which was not associated with a variation in the amount of receptor proteins (as measured by Western blots), supports the hypothesis of direct interactions between α "A -AR isoforms. These molecular interactions probably lead to a modification of the conformation of the α "A−" receptors that would account for the loss of [$H]prazosin-binding sites. In that perspective, the loss of binding sites observed at surface of the cotransfected cells, which could be explained by impaired trafficking of the receptors, could also be the result of an alteration of the receptor conformation. Both molecular mechanisms could be the consequence of heterodimer formation between α "A−" -AR and the truncated isoforms. Surprisingly, the loss of binding sites both in the intracellular pool and at the cell surface observed in co-expression experiments was accompanied by a very slight decrease in the noradrenaline-stimulated [Ca# + ] i response ( Table  2 ), suggesting that, in our experimental conditions, only a small portion of α "A -AR was required at the cell surface to obtain a maximal increase in [Ca# + ] i or that the interaction between α "A−" -AR and the truncated isoforms did not strongly alter this transduction pathway. For the V # and gonadotropin-releasing hormone receptors, an excess (15-fold) of splice variant cDNA in comparison with the wild type was necessary to observe a decrease of 50 % in agonist-induced cAMP accumulation and phosphoinositide hydrolysis respectively. However, one could note that such an excess of splice variant might not be observed under physiological conditions. Recently, Berts et al. [33] suggested that Ca# + release and protein kinase C activation were neither necessary nor sufficient for the α "A -AR-mediated activation of mitogenic responses in PC12 cells. It would therefore be interesting to analyse the possibility that truncated α "A -AR isoforms could modulate more specifically this new transduction pathway of α "A−" -AR. Negative regulation of wild-type receptors by their mutant truncated counterparts, reported for the V # receptors, was correlated with the formation of heterodimers between wild-type and mutant receptors [19] . However, the proportion of heterodimers compared with the total amount of oligomers displayed in immunoblotting experiments was particularly small to account entirely for the negative activity of mutant receptors on wild-type V # receptors, thus suggesting a possible lack of stability of such heterodimers under SDS\PAGE conditions. Although no heterodimers between the full-length α "A-" -AR and the truncated α "A -AR isoforms were found by immunoblotting, a large number of pieces of evidence suggested the existence of direct interactions between α "A−" -AR and the truncated isoforms. A small proportion (5 %) of cells co-expressing truncated M5-tagged α "A−$c -AR, which was unable to traffic to the plasma membrane when expressed alone, and untagged α "A−" receptors exhibited a fluorescent signal at the cell surface. This modification in the subcellular localization of the α "A−$c -AR isoform when co-expressed with full-length α "A−" -AR supported the hypothesis of an interaction between truncated isoforms and the full-length receptor, interaction that would interfere with the proper intracellular trafficking of two receptors and would allow cell-surface trafficking of the α "A−$c -AR. In addition, Western blot analysis revealed that all isolated α "A -AR isoforms expressed in COS-7 cells were present as glycosylated monomeric, dimeric, trimeric and tetrameric forms ( Figure 5A ). Such oligomeric structures resistant to SDS, heat and reducing agents have been observed for the human β # -adrenergic receptor [34] . Hebert et al. [34] demonstrated that Gly-276, Gly-280 and Leu-284 residues, which belong to TM6 of the β # -adrenergic receptor, had a crucial role in the dimerization of this receptor. Interestingly, the cytoplasmic end of TM6 of α "A -AR (#(%LGIVVGCFVL#)$) shared 60 % identity with the human β # -adrenergic receptor (#(&LGIIMGTF-TL#)%) and the positions of leucine and glycine residues were preserved. Hebert et al. [35] also showed that a peptide based on the sequence of TM6 of the β # -adrenergic receptor was able to disrupt dimerization and adenylate cyclase activation of the β # receptor. The same kind of biochemical event occurred with the dopamine D " receptor, for which the D " R TM6 peptide might interact with native TMs to alter the three-dimensional conformation of the D " receptor and modify its ligand and signal transduction properties without disrupting the homodimer [36] . Our results suggest that the truncated α "A -AR isoforms isolated in our study could interact directly with functional α "A−" -AR oligomers, possibly via TM6. Similarly to the dopamine D " receptor, this interaction would modify the binding capacity and intracellular trafficking of α "A−" -AR without either the production of SDS-stable heterodimers or the disruption of the α "A−" -AR oligomers.
In summary, we present for the first time the existence of interactions between α "A−" -AR and other α "A -AR isoforms. The existence of a large number of truncated α "A -AR isoforms that could interfere with α "A−" -AR suggests that these truncated isoforms might have a role in some pathologies involving α "A -AR, such as benign prostate hyperplasia and myocardial hypertrophy. These interactions might constitute a novel mechanism regulating the biological properties of α "A -AR that does not exist for the human α "B -AR and α "D -AR isoforms, thus opening new avenues for the pharmacologist.
